This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm: Connective and other soft tissue of head, face and neck
CD2_BENIGN_CONNSOFT_HEADFACETRUNK
head and neck malignant neoplasia: A primary or metastatic malignant neoplasm affecting the head and neck. Representative examples include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
649 |
4. Check minimum number of eventsNone |
649 |
5. Include endpointsNone |
649 |
6. Filter based on genotype QC (FinnGen only) |
629 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D21
- Name in latin
- Neoplasma benignum textus connectivi capitis/faciei
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Connective and other soft tissue of head, face and neck
based on the number of shared cases.
Similar with more cases:
- Other benign neoplasms of connective and other soft tissue
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 629 | 341 | 288 |
| Unadjusted period prevalence (%) | 0.13 | 0.12 | 0.13 |
| Median age at first event (years) | 46.41 | 41.59 | 52.11 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 649
- Matched controls
- 6490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D21.0
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of head, face and neck
11106.9
307.7
494
*
21501
ICD-8 Finland
Other benign neoplasm of muscular and connective tissue, Capitis (facie inclusa) et colli
+∞
116.2
108
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.9
109.1
178
295
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
6.7
37.5
62
100
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
7.7
30.0
43
59
D17.0
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck
10.2
29.7
34
35
2150A
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Head, face and neck[NEOPL BENIG CAPITIS, FACIEI ET COLLI,SIDEKUDOSPER]
+∞
25.2
24
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
6.0
23.2
42
74
CBB30
NOMESCO Finland
Excision of lesion of eyelid
5.5
18.0
35
66
2150X
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Head, face and neck[NEOPL BENIG CAPITIS, FACIEI ET COLLI,TARK MÄÄRITT]
+∞
14.6
14
*
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
5.5
13.8
27
51
4704
FHL
Neck tumor removal
142.9
13.5
14
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.2
13.0
53
175
D18.0
ICD-10 Finland
Haemangioma, any site
5.3
12.3
25
49
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.0
11.0
50
176
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
5.1
10.1
21
42
ZXA00
NOMESCO Finland
Right side
1.8
10.0
175
1086
DAB00
NOMESCO Finland
Excision of lesion of auricle
7.8
8.7
19
25
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
4.7
8.6
20
44
WX002
NOMESCO Finland
Sedation and analgesia
1.9
8.4
125
733
NAR99
NOMESCO Finland
Other operation for tumour of spine, unspecified
+∞
8.3
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
8.0
235
1669
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
45.5
7.7
9
*
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.5
7.5
47
196
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
7.3
157
1025
D21.1
ICD-10 Finland
Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder
10.2
7.1
13
13
UDC00
NOMESCO Finland
Ear microscopy
2.3
7.0
54
248
CBA10
NOMESCO Finland
Biopsy of eyelid
7.6
6.9
15
20
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
8.4
6.9
14
17
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
4.0
6.7
19
49
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
10.2
6.6
12
12
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
3.3
6.5
24
75
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
3.3
6.5
24
75
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
4.1
6.4
17
42
QAE00
NOMESCO Finland
Excision of loose skin or fold of skin from head and neck
11.2
6.3
11
10
S18
ICPC
Laceration/cut
1.5
6.3
270
2065
CBB99
NOMESCO Finland
Other excision or destruction of lesion of eyelid
18.2
6.3
9
5
D18.1
ICD-10 Finland
Lymphangioma, any site
+∞
6.3
6
*
2150D
ICD-9 Finland
Other benign neoplasm of connective and other soft tissue, Head, face and neck[NEOPL BENIG CAPITIS, FACIEI ET COLLI,MUU]
+∞
6.3
6
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
6.4
6.2
15
24
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
304
2446
1.46
5.22
7.3
6.5
1.21
1.21
mmol/l
0.16
272
2088
266
2087
1.47
5.21
4.3
4.8
35.86
35.92
g/l
0.06
254
1957
165
1206
1.49
4.51
2.1
2.3
—
—
—
0
0
168
1265
1.44
3.89
3.4
3.8
91.62
91.41
%
0.04
162
1237
256
2077
1.38
3.86
2.5
2.3
78.02
75.82
nmol/l
0.57
231
1867
28
128
2.24
3.75
1.2
1.2
—
—
—
0
0
239
1944
1.36
3.46
1.9
1.9
94.49
94.63
pmol/l
0.02
133
1018
129
943
1.46
3.46
3.6
3.7
706.02
247.59
ng/l
0.48
93
701
56
344
1.69
3.21
4.5
3.7
78.35
77.49
ng/l
0.04
50
310
282
2400
1.31
2.87
2.6
2.5
—
—
—
0
0
262
2208
1.31
2.86
6.3
5.9
1.21
1.21
mmol/l
0.29
245
2022
332
2916
1.28
2.56
5.1
4.7
6.61
6.67
mmol/l
0.20
314
2710
421
3822
1.29
2.45
4.6
4.0
12.09
11.55
mm/h
0.29
396
3530
157
1260
1.32
2.37
2.3
2.0
2.65
3.04
mg/l
1.73
134
1079
429
3913
1.28
2.36
8.3
7.3
76.46
77.57
u/l
0.23
404
3683
57
383
1.54
2.32
2.5
2.9
149.59
185.18
ng/l
0.28
49
346
47
302
1.60
2.32
7.2
9.3
0.73
0.69
%
0.26
47
297
38
231
1.69
2.32
1.6
1.3
31.83
27.46
iu/l
0.28
30
197
47
304
1.59
2.26
7.0
9.1
1.23
1.38
%
0.69
47
299
27
152
1.81
2.15
1.1
1.1
0.72
9.97
u/ml
—
5
21
429
3934
1.27
2.15
4.7
3.8
14.82
14.70
pmol/l
0.52
404
3564
507
4750
1.31
2.12
5.6
4.5
1.81
1.89
mu/l
0.95
473
4353
198
1664
1.27
2.09
3.1
3.3
2.35
2.35
mmol/l
0.32
181
1490
261
2271
1.25
2.04
15.4
12.2
1.16
1.22
inr
0.64
71
674
203
1719
1.26
2.00
3.4
3.3
31.93
31.48
u/l
0.03
195
1647
75
552
1.41
1.96
6.5
8.3
0.66
1.12
mmol/l
0.49
59
435
175
1467
1.26
1.87
2.1
2.1
167.57
251.95
u/l
0.96
165
1390
27
162
1.70
1.77
2.7
3.0
—
—
—
0
0
31
197
1.60
1.66
2.0
1.9
—
—
—
0
0
7
25
2.82
1.65
5.1
4.3
81.43
118.84
nmol/l
—
7
25
546
5218
1.29
1.61
14.6
13.4
22.08
23.34
mg/l
0.40
442
4089
25
152
1.67
1.59
1.5
1.7
47.20
40.63
nmol/l
0.27
25
145
27
168
1.63
1.57
1.4
2.1
—
—
—
0
0
256
2272
1.21
1.57
3.0
2.7
103.26
114.88
ug/l
0.70
240
2106
11
52
2.13
1.45
1.6
1.3
63.50
60.80
%
—
6
40
51
373
1.40
1.43
1.2
1.2
102.24
160.36
iu/ml
0.50
16
154
6
23
2.62
1.37
1.2
1.3
—
—
—
0
0
25
159
1.60
1.36
1.7
1.5
53.77
0.06
iu/ml
—
6
28
92
742
1.28
1.35
2.0
2.2
13.96
13.29
umol/l
0.40
86
694
181
1579
1.20
1.30
2.5
2.4
79.02
59.56
u/l
0.53
169
1471
53
398
1.36
1.29
3.0
2.6
78.04
68.71
ml/min/173m2
1.09
24
170
11
55
2.02
1.28
1.1
1.1
—
—
—
0
0
84
681
1.27
1.20
2.0
2.2
2.43
2.36
g/l
0.62
79
633
13
71
1.85
1.20
1.1
1.4
7.71
7.37
mmol/l
—
7
58
29
198
1.49
1.19
1.3
1.2
3.20
2.55
u/ml
—
5
11
12
64
1.89
1.18
1.2
1.3
0.57
0.54
nmol/l
0.11
12
58
290
2653
1.17
1.18
6.8
6.1
10.91
11.25
umol/l
0.29
279
2524
108
907
1.23
1.14
2.3
3.0
2.43
2.44
mmol/l
0.34
94
798
104
871
1.23
1.13
1.2
1.3
13.25
11.72
u/ml
0.06
48
345
118
1002
1.22
1.12
1.7
1.5
—
—
—
0
0
517
4969
1.20
1.08
4.7
4.3
5.87
5.91
mmol/l
0.32
479
4557
78
636
1.26
1.08
2.1
2.2
21.19
22.79
%
0.63
64
556
276
2530
1.16
1.07
6.2
5.9
28.09
28.13
%
0.02
260
2380
568
5514
1.24
1.04
11.3
9.9
25.71
26.24
u/l
0.27
553
5333
7
34
2.07
1.03
1.1
1.2
—
—
—
0
0
100
844
1.22
1.02
2.8
2.7
0.70
1.03
e6/l
0.85
64
459
24
164
1.48
1.00
1.0
1.2
—
—
—
0
0
7
35
2.01
1.00
1.0
1.1
—
—
—
0
0
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
18
116
1.57
0.97
1.1
1.8
—
—
—
0
0
7
36
1.95
0.97
1.3
1.3
—
—
—
0
0
70
573
1.25
0.95
6.4
6.9
—
—
—
0
0
26
183
1.44
0.95
1.9
1.7
—
—
—
0
0
11
62
1.79
0.94
1.0
1.2
—
—
—
0
0
179
1986
0.86
0.92
3.6
3.6
—
—
—
0
0
6
28
2.15
0.91
1.0
1.4
1.54
1.57
g/l
—
6
28
174
1559
1.16
0.90
3.4
3.2
8.02
7.82
mmol/l
0.20
149
1319
39
298
1.33
0.90
1.4
1.3
—
—
—
0
0
95
809
1.20
0.90
1.9
1.9
—
—
—
0
0
20
136
1.49
0.87
1.2
1.2
3.30
7.77
u/ml
—
5
21
41
318
1.31
0.86
3.1
4.0
2.21
1.66
mmol/l
0.52
36
237
17
112
1.53
0.85
1.5
1.6
7690.08
14709.93
e6/l
0.65
12
84
101
870
1.19
0.85
1.7
1.7
1032.00
1183.41
nmol/l
1.22
82
661
138
1221
1.17
0.84
1.4
1.3
2.72
1.79
u/ml
0.33
39
335
25
180
1.40
0.83
1.3
1.3
—
—
—
0
0
23
163
1.43
0.83
1.0
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
138
1.46
0.82
3.6
2.5
0.28
0.34
u/ml
0.44
12
74
545
5297
1.18
0.82
17.0
15.4
3.96
3.97
mmol/l
0.26
531
5153
269
2499
1.13
0.81
6.1
5.7
56.67
57.01
%
0.18
251
2352
506
4893
1.15
0.80
3.7
3.8
1.32
1.28
mmol/l
0.30
475
4529
129
1142
1.16
0.79
1.6
1.5
20.73
20.66
nmol/l
0.02
115
981
0
26
0.00
0.78
0.0
1.0
—
—
—
0
0
367
3482
1.12
0.77
3.1
3.2
—
—
—
0
0
0
28
0.00
0.76
0.0
3.8
—
—
—
0
0
239
2573
0.89
0.76
3.7
3.5
0.00
0.01
estimate
0.50
44
483
522
5065
1.16
0.76
4.2
4.1
1.44
1.46
mmol/l
0.36
492
4706
11
67
1.65
0.75
5.1
1.9
13.65
13.20
%
0.49
11
67
9
54
1.68
0.74
1.0
1.1
—
—
—
0
0
524
5088
1.16
0.74
4.3
4.2
4.67
4.66
mmol/l
0.07
500
4761
7
38
1.85
0.73
1.1
1.2
—
79.00
—
0
6
71
601
1.20
0.73
2.4
2.8
12.71
7.59
umol/l
0.37
60
530
18
125
1.45
0.73
1.1
1.5
473.06
493.48
mg/l
0.09
18
119
9
56
1.62
0.72
1.0
1.1
—
—
—
0
0
5
27
1.86
0.68
1.4
1.2
—
—
—
0
0
5
27
1.86
0.68
1.4
1.2
—
—
—
0
0
21
153
1.39
0.68
2.5
3.4
3.81
3.93
mmol/l
0.75
21
148
24
179
1.35
0.67
2.4
3.9
1.78
1.37
mmol/l
0.59
24
172
5
95
0.52
0.66
1.4
1.6
—
—
—
0
0
532
5183
1.15
0.66
4.8
4.7
2.77
2.77
mmol/l
0.03
502
4813
5
28
1.79
0.66
1.4
1.3
—
—
—
0
0
5
28
1.79
0.66
1.4
1.3
—
—
—
0
0
237
2535
0.90
0.66
3.6
3.5
0.00
0.00
estimate
0.50
49
532
238
2542
0.90
0.64
4.7
4.8
0.00
0.00
estimate
-0.00
47
503
11
71
1.56
0.62
2.0
1.5
0.42
0.35
nmol/l
0.15
11
59
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
5
30
1.67
0.61
1.4
1.7
—
—
—
0
0
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
125
1380
0.88
0.60
4.1
3.7
0.00
0.01
estimate
0.69
46
494
162
1486
1.12
0.60
4.0
3.8
6.83
10.20
mg/mmol
0.64
98
941
8
52
1.55
0.59
8.8
3.3
31.75
48.87
u/ml
—
8
52
47
392
1.21
0.59
2.5
1.9
—
—
—
0
0
35
283
1.25
0.58
1.1
1.0
—
—
—
0
0
6
35
1.72
0.58
1.0
1.5
—
—
—
0
0
15
107
1.41
0.55
1.2
1.3
266.33
243.53
u/ml
—
9
55
100
895
1.14
0.55
1.2
1.3
24.86
34.35
iu/ml
0.86
34
303
590
5807
1.18
0.55
22.3
19.6
254.98
250.53
e9/l
0.91
580
5683
6
38
1.58
0.54
1.2
1.3
234.50
316.48
u/l
—
6
38
9
61
1.48
0.54
1.3
1.1
—
—
—
0
0
140
1283
1.12
0.53
2.1
2.6
3877.33
5531.36
umol/l
0.18
123
1128
52
444
1.19
0.52
2.8
3.6
5.85
5.76
kpa
0.30
52
428
9
63
1.43
0.52
1.0
1.1
—
—
—
0
0
9
133
0.67
0.52
3.0
1.6
—
—
—
0
0
138
1265
1.12
0.52
4.6
4.1
23.66
21.10
%
0.96
63
577
540
5288
1.13
0.52
16.9
15.3
139.83
139.66
mmol/l
0.96
529
5152
91
814
1.14
0.51
2.9
2.9
2.38
2.35
e6/l
0.02
55
432
153
1412
1.11
0.51
3.2
3.0
0.36
0.46
e6/l
0.31
119
1059
590
5812
1.17
0.51
22.3
19.6
4.53
4.52
e12/l
0.24
577
5674
6
41
1.47
0.50
3.8
2.6
—
—
—
0
0
169
1570
1.10
0.50
5.0
4.7
2.06
2.63
ug/l
0.92
152
1400
19
145
1.32
0.49
2.1
1.9
10.11
11.52
mg/l
0.44
19
132
51
438
1.18
0.49
2.8
3.6
1.86
1.95
mmol/l
0.06
46
348
590
5815
1.16
0.49
22.4
19.8
135.37
135.89
g/l
0.40
585
5742
148
1368
1.11
0.48
2.7
3.1
1486.75
1221.71
ng/l
0.35
129
1164
314
3006
1.09
0.48
9.6
9.0
3.84
4.06
e9/l
1.23
274
2624
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
589
5808
1.15
0.46
22.2
19.7
40.59
40.34
%
0.58
545
5453
5
84
0.59
0.45
2.6
1.5
—
—
—
0
0
7
50
1.40
0.45
4.4
3.8
—
—
—
0
0
15
112
1.35
0.45
1.2
1.3
—
—
—
0
0
7
51
1.38
0.44
1.3
1.7
—
—
—
0
0
7
51
1.38
0.44
1.3
1.7
—
—
—
0
0
7
51
1.38
0.44
1.3
1.7
—
—
—
0
0
42
359
1.18
0.44
1.4
1.6
—
—
—
0
0
101
921
1.11
0.43
3.2
3.0
0.83
0.75
ug/l
0.34
68
579
16
122
1.32
0.42
1.3
1.3
—
—
—
0
0
28
231
1.22
0.42
3.1
3.8
24.76
24.22
mmol/l
0.56
28
225
84
760
1.12
0.41
1.7
2.0
29.73
29.66
s
0.04
79
743
8
59
1.36
0.41
1.1
1.5
—
—
—
0
0
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
0
18
0.00
0.40
0.0
1.2
—
387.60
—
0
10
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
17
133
1.29
0.39
1.2
1.3
—
—
—
0
0
9
66
1.37
0.38
1.3
1.7
—
—
—
0
0
5
36
1.39
0.38
1.0
1.4
—
—
—
0
0
5
36
1.39
0.38
1.4
1.6
—
—
—
0
0
5
36
1.39
0.38
1.0
1.0
—
—
—
0
0
17
134
1.28
0.37
1.8
1.3
—
—
—
0
0
5
37
1.35
0.37
1.0
1.8
—
—
—
0
0
6
42
1.43
0.35
2.0
1.2
9975.00
23110.53
e6/l
—
6
30
55
493
1.13
0.33
1.9
2.3
40.54
32.22
u/l
0.52
50
416
14
110
1.28
0.32
1.1
1.4
3.60
3.73
mmol/l
0.19
14
103
192
1832
1.07
0.31
3.3
3.1
—
—
—
0
0
24
203
1.19
0.30
2.8
2.2
9550.88
2768.42
u/l
—
5
83
20
166
1.21
0.30
1.3
1.7
—
207.50
—
0
8
36
316
1.15
0.30
1.2
1.3
—
45.67
—
0
19
477
4685
1.07
0.30
5.8
5.4
39.59
39.67
mmol/mol
0.07
447
4384
20
167
1.20
0.28
1.5
1.4
—
—
—
0
0
16
131
1.23
0.27
1.1
1.2
—
—
—
0
0
8
65
1.23
0.27
5.9
5.4
335.88
377.29
umol/l
—
8
56
62
568
1.10
0.27
1.9
1.9
—
—
—
0
0
113
1064
1.08
0.27
2.5
2.5
5.33
5.52
e6/l
0.05
99
961
5
75
0.66
0.26
1.6
1.3
—
—
—
0
0
16
133
1.21
0.24
1.5
2.5
41.51
68.59
ug/min
—
10
81
17
201
0.84
0.24
1.8
1.8
—
—
—
0
0
65
602
1.09
0.23
4.8
4.3
31.67
31.35
%
0.08
54
410
5
39
1.28
0.23
1.0
1.0
—
—
—
0
0
13
157
0.82
0.22
1.2
1.5
—
—
—
0
0
5
40
1.25
0.22
1.0
1.7
—
—
—
0
0
61
565
1.09
0.22
1.9
1.8
—
—
—
0
0
5
42
1.19
0.21
1.8
1.3
59046.00
32247.19
e6/l
—
5
26
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
2.3
—
2.54
—
0
5
11
89
1.24
0.21
1.5
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
45
488
0.92
0.19
3.6
3.3
—
—
—
0
0
7
59
1.19
0.18
1.4
1.8
—
—
—
0
0
8
72
1.11
0.16
1.3
1.3
—
—
—
0
0
8
72
1.11
0.16
1.3
1.3
—
—
—
0
0
110
1145
0.95
0.16
1.7
1.8
2.00
1.12
mg/l
0.34
81
877
8
73
1.10
0.15
1.0
1.6
—
—
—
0
0
8
73
1.10
0.15
1.3
1.3
—
—
—
0
0
6
78
0.77
0.15
1.0
1.1
—
—
—
0
0
10
83
1.21
0.15
1.0
1.6
—
—
—
0
0
106
1019
1.05
0.15
1.8
1.7
405.58
26932508.22
pmol/l
1.29
93
854
26
285
0.91
0.14
1.8
1.7
—
—
—
0
0
69
725
0.95
0.14
2.4
2.2
—
—
—
0
0
16
180
0.89
0.13
1.3
1.4
386.86
252.92
miu/ml
—
7
92
9
110
0.82
0.13
1.6
1.7
—
—
—
0
0
63
661
0.95
0.12
2.5
2.0
—
—
—
0
0
15
133
1.13
0.12
1.1
1.7
—
—
—
0
0
11
95
1.16
0.11
1.2
1.8
—
—
—
0
0
12
136
0.88
0.11
1.1
1.1
—
—
—
0
0
5
44
1.14
0.10
1.0
1.2
—
—
—
0
0
492
4886
1.03
0.09
14.5
12.2
83.79
83.46
ml/min/173m2
0.12
407
3996
34
321
1.06
0.09
2.6
1.8
—
—
—
0
0
6
56
1.07
0.08
4.8
1.7
12.58
16.68
ug/l
—
6
56
5
60
0.83
0.08
1.0
1.8
—
—
—
0
0
5
64
0.78
0.08
1.0
1.7
—
—
—
0
0
5
64
0.78
0.08
1.0
1.7
—
—
—
0
0
7
65
1.08
0.08
1.6
1.2
—
—
—
0
0
186
1890
0.98
0.08
3.5
3.6
64.51
59.80
ng/l
0.05
125
1281
8
74
1.08
0.07
1.3
1.3
—
—
—
0
0
8
74
1.08
0.07
1.3
1.3
—
—
—
0
0
8
75
1.07
0.07
1.0
1.7
—
—
—
0
0
335
3379
0.98
0.07
4.6
4.2
2200.20
1601.26
e6/l
—
5
57
19
178
1.07
0.05
1.7
2.1
—
—
—
0
0
25
263
0.95
0.05
1.2
1.5
—
—
—
0
0
11
100
1.10
0.05
4.6
3.8
59.91
56.93
%
0.35
11
100
29
278
1.05
0.04
2.2
2.8
0.51
0.13
e6/l
0.73
29
270
14
130
1.08
0.04
1.1
1.7
—
—
—
0
0
459
4570
1.01
0.04
17.5
16.1
15.15
14.74
%
0.70
454
4503
21
221
0.95
0.04
1.0
1.6
3.35
3.86
mg/l
0.19
12
167
31
300
1.04
0.03
1.9
1.4
—
—
—
0
0
351
3497
1.01
0.02
3.0
3.0
40.52
45.62
u/l
0.83
333
3288
39
381
1.03
0.02
2.7
3.0
4.52
4.44
kpa
0.09
39
364
82
830
0.99
0.02
1.5
1.4
—
—
—
0
0
155
1561
0.99
0.02
3.3
3.1
198.27
113.22
e6/l
0.19
122
1201
10
93
1.08
0.02
1.2
1.7
—
—
—
0
0
10
93
1.08
0.02
1.2
1.7
—
—
—
0
0
12
113
1.06
0.02
1.4
1.4
—
—
—
0
0
65
657
0.99
0.01
1.7
1.8
1.34
1.47
%
0.78
57
590
14
145
0.96
0.00
1.1
1.4
—
—
—
0
0
14
145
0.96
0.00
1.1
1.4
—
—
—
0
0
16
165
0.97
0.00
1.4
1.5
—
—
—
0
0
14
144
0.97
0.00
1.1
1.4
—
—
—
0
0
14
144
0.97
0.00
1.1
1.4
—
—
—
0
0
15
154
0.97
0.00
2.7
1.5
—
—
—
0
0
10
97
1.03
0.00
5.0
3.4
4.40
4.25
e9/l
—
10
97
12
123
0.98
0.00
1.4
1.6
—
—
—
0
0
50
505
0.99
0.00
4.5
4.2
14.45
37.88
ug/l
0.70
38
418
17
172
0.99
0.00
2.1
1.6
—
—
—
0
0
18
178
1.01
0.00
1.2
1.4
—
—
—
0
0
50
498
1.00
0.00
1.6
1.7
—
—
—
0
0
114
1138
1.00
0.00
3.9
3.7
1.02
1.02
kg/l
0.46
12
153
137
1371
1.00
0.00
1.8
1.6
1.27
1.40
mmol/l
1.14
119
1152
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
110.38
—
0
8
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
9
92
0.98
-0.00
1.3
1.5
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
65.67
—
0
6
7
72
0.97
-0.00
1.0
1.6
—
—
—
0
0
9
95
0.95
-0.00
1.0
1.6
—
—
—
0
0
8
82
0.98
-0.00
1.0
1.1
—
—
—
0
0
9
97
0.93
-0.00
1.3
1.3
—
—
—
0
0
7
73
0.96
-0.00
1.3
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
97
0.93
-0.00
1.3
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
82
0.98
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
51
0.98
-0.00
1.4
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_CONNSOFT_HEADFACETRUNK – Benign neoplasm: Connective and other soft tissue of head, face and neck
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).